SCHEMBL5705022

SCHEMBL5705022

CN=C1SCC(=O)N1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5705020 1.00 — —
SCHEMBL10810312 0.80 — —
SCHEMBL23094486 0.77 ALDH1A1 (0.51) —
SCHEMBL23794087 0.76 — —
SCHEMBL17813824 0.74 ALDH1A1 (0.49) —
SCHEMBL23094679 0.74 ALDH1A1 (0.51) —
SCHEMBL17813784 0.72 ALDH1A1 (0.44) —
SCHEMBL2589792 0.71 MEN1 (0.68) —
SCHEMBL2589796 0.71 MEN1 (0.68) —
SCHEMBL686422 0.70 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1323714-B1 1,3-selenazole derivatives and their use as anticancer drugs or as agrochemicals PRESIDENT OF GIFU UNIVERSITY (JP) 2006-09-20 — — EP disclosed
Send feedback